| Literature DB >> 26904168 |
Mariana Janini Gomes1, Paula Felippe Martinez1, Dijon Henrique Salomé Campos1, Luana Urbano Pagan1, Camila Bonomo1, Aline Regina Ruiz Lima1, Ricardo Luiz Damatto1, Marcelo D M Cezar1, Felipe Cezar Damatto1, Camila Moreno Rosa1, Camila Marchiolli Garcia1, David Rafael Abreu Reyes1, Ana Angélica Henrique Fernandes2, Denise Castro Fernandes3, Francisco Rafael Laurindo3, Katashi Okoshi1, Marina Politi Okoshi1.
Abstract
Objective. We evaluated the influence of exercise on functional capacity, cardiac remodeling, and skeletal muscle oxidative stress, MAPK, and NF-κB pathway in rats with aortic stenosis- (AS-) induced heart failure (HF). Methods and Results. Eighteen weeks after AS induction, rats were assigned into sedentary control (C-Sed), exercised control (C-Ex), sedentary AS (AS-Sed), and exercised AS (AS-Ex) groups. Exercise was performed on treadmill for eight weeks. Statistical analyses were performed with Goodman and ANOVA or Mann-Whitney. HF features frequency and mortality did not differ between AS groups. Exercise improved functional capacity, assessed by maximal exercise test on treadmill, without changing echocardiographic parameters. Soleus cross-sectional areas did not differ between groups. Lipid hydroperoxide concentration was higher in AS-Sed than C-Sed and AS-Ex. Activity of antioxidant enzymes superoxide dismutase and glutathione peroxidase was changed in AS-Sed and restored in AS-Ex. NADPH oxidase activity and gene expression of its subunits did not differ between AS groups. Total ROS generation was lower in AS-Ex than C-Ex. Exercise modulated MAPK in AS-Ex and did not change NF-κB pathway proteins. Conclusion. Exercise improves functional capacity in rats with AS-induced HF regardless of echocardiographic parameter changes. In soleus, exercise reduces oxidative stress, preserves antioxidant enzyme activity, and modulates MAPK expression.Entities:
Mesh:
Substances:
Year: 2016 PMID: 26904168 PMCID: PMC4745811 DOI: 10.1155/2016/8695716
Source DB: PubMed Journal: Oxid Med Cell Longev ISSN: 1942-0994 Impact factor: 6.543
Frequency of heart failure features in the aortic stenosis rats.
| Frequency (%) | ||
|---|---|---|
| AS-Sed ( | AS-Ex ( | |
| Tachypnea/labored respiration | 22.2 | 16.7 |
| Left atrial thrombi | 33.3 | 38.9 |
| Pleuropericardial effusion | 66.7 | 55.6 |
| Hepatic congestion | 16.7 | 11.1 |
| Pulmonary congestion | 66.7 | 66.7 |
| Right ventricular hypertrophy | 72.2 | 61.1 |
| Ascites | 22.2 | 5.60 |
AS-Sed: sedentary aortic stenosis group; AS-Ex: exercised aortic stenosis group; n: number of animals. Goodman test; p > 0.05.
Anatomical data.
| C-Sed ( | C-Ex ( | AS-Sed ( | AS-Ex ( | |
|---|---|---|---|---|
| BW (g) | 454 ± 57.4 | 466 ± 64.6 | 435 ± 35.8 | 439 ± 47.8 |
| LVW (mg) | 0.92 (0.86–0.99) | 0.96 (0.84–1.04) | 1.40 (1.28–1.73) | 1.36 (1.23–1.50)† |
| LVW/BW (mg/g) | 1.95 (1.78–1.99) | 1.88 (1.67–2.11) | 3.17 (2.67–3.86) | 3.35 (2.74–3.84)† |
| RVW (mg) | 0.24 (0.21–0.25) | 0.23 (0.21–0.28) | 0.45 (0.31–0.55) | 0.43 (0.26–0.54)† |
| RVW/BW (mg/g) | 0.48 (0.42–0.51) | 0.50 (0.41–0.56) | 0.99 (0.76–1.22) | 0.98 (0.62–1.28)† |
| Atria (mg) | 0.09 (0.07–0.10) | 0.09 (0.08–0.11) | 0.31 (0.27–0.38) | 0.27 (0.15–0.35)† |
| Atria/BW (mg/g) | 0.19 (0.14–0.21) | 0.19 (0.16–0.23) | 0.68 (0.59–0.87) | 0.68 (0.59–0.87)† |
| Lung (mg) | 1.84 (1.65–2.02) | 1.78 (1.48–2.03) | 3.35 (2.31–4.08) | 3.15 (2.11–3.50)† |
| Lung/BW (mg/g) | 3.84 (3.54–4.25) | 3.60 (2.98–4.12) | 6.58 (4.40–8.10) | 7.36 (4.83–10.25)† |
| Soleus (g) | 0.25 ± 0.05 | 0.22 ± 0.05 | 0.22 ± 0.04 | 0.21 ± 0.03 |
| Soleus/BW (mg/g) | 0.50 ± 0.10 | 0.45 ± 0.11 | 0.48 ± 0.07 | 0.49 ± 0.09 |
| Gastro (g) | 2.67 ± 0.33 | 2.70 ± 0.29 | 2.44 ± 0.33 | 2.42 ± 0.27† |
| Gastro/BW (mg/g) | 5.39 ± 0.41 | 5.51 ± 0.44 | 5.33 ± 0.54 | 5.54 ± 0.41 |
C-Sed: sedentary control group; C-Ex: exercised control group; AS-Sed: sedentary aortic stenosis group; AS-Ex: exercised aortic stenosis group; BW: body weight; LVW: left ventricle weight; RVW: right ventricle weight; Gastro: gastrocnemius muscle weight. Data are mean ± SD or median and percentiles; ANOVA and Tukey or Mann-Whitney; p < 0.05 versus C-Sed; † p < 0.05 versus C-Ex.
Maximal exercise test before and after physical training.
| C-Sed ( | C-Ex ( | AS-Sed ( | AS-Ex ( | |
|---|---|---|---|---|
| Distance | ||||
| Before | 257 ± 86.5 | 247 ± 55.8 | 171 ± 59.7 | 163 ± 35.5† |
| After | 225 ± 64.8 | 304 ± 47.5 | 154 ± 48.9 | 254 ± 47.2†‡ |
|
| ||||
| Time | ||||
| Before | 22.8 ± 4.10 | 22.7 ± 2.53 | 18.5 ± 3.16 | 18.1 ± 2.16† |
| After | 21.7 ± 3.51 | 25.1 ± 1.94 | 18.0 ± 3.05 | 22.7 ± 2.61†‡ |
C-Sed: sedentary control group; C-Ex: exercised control group; AS-Sed: sedentary aortic stenosis group; AS-Ex: exercised aortic stenosis group. Data are mean ± SD; ANOVA and Tukey; p < 0.05 versus C-Sed; † p < 0.05 versus C-Ex; ‡ p < 0.05 versus AS-Sed.
Echocardiographic structural data.
| C-Sed ( | C-Ex ( | AS-Sed ( | AS-Ex ( | |
|---|---|---|---|---|
| LVDD (mm) | 8.30 ± 0.55 | 8.50 ± 0.55 | 9.02 ± 0.85 | 9.17 ± 0.74† |
| LVDD/BW (mm/kg) | 16.6 ± 2.05 | 16.8 ± 1.91 | 18.9 ± 2.69 | 20.4 ± 3.09† |
| LVSD (mm) | 4.05 ± 0.55 | 4.30 ± 0.60 | 4.81 ± 1.17 | 5.27 ± 0.98† |
| DPWT (mm) | 1.42 (1.38–1.46) | 1.38 (1.31–1.44) | 2.06 (1.84–2.12) | 1.99 (1.84–2.17)† |
| SPWT (mm) | 3.01 (2.76–3.14) | 2.69 (2.65–3.00) | 3.60 (2.86–3.79) | 3.49 (2.91–3.72)† |
| DSWT (mm) | 1.43 (1.40–1.46) | 1.38 (1.34–1.46) | 2.11 (1.84–2.16) | 2.01 (1.84–2.17)† |
| SSWT (mm) | 2.52 (2.42–2.65) | 2.42 (2.33–2.59) | 2.79 (2.59–3.16) | 2.93 (2.68–3.25)† |
| RWT | 0.34 (0.33–0.36) | 0.33 (0.31–0.34) | 0.44 (0.38–0.48) | 0.42 (0.40–0.50)† |
| AO (mm) | 4.02 (3.83–4.16) | 4.02 (3.83–4.16) | 3.94 (3.80–4.16) | 3.94 (3.80–4.09) |
| LA (mm) | 5.29 (4.93–5.69) | 5.66 (5.47–5.99) | 8.54 (7.88–8.69) | 8.14 (6.79–8.54)† |
| LA/AO | 1.32 (1.26–1.38) | 1.43 (1.30–1.52) | 2.17 (1.83–2.29) | 2.09 (1.67–2.24)† |
| LA/BW (mm/kg) | 10.3 (9.5–12.1) | 10.9 (10.0–12.3) | 17.3 (14.8–19.5) | 17.3 (15.7–18.9)† |
| LVM (g) | 0.82 (0.77–0.89) | 0.83 (0.74–0.93) | 1.62 (1.18–1.87) | 1.38 (1.32–1.93)† |
| LVMI (g/kg) | 1.69 (1.44–1.88) | 1.64 (1.47–1.85) | 2.81 (2.69–3.67) | 3.40 (2.66–4.16)† |
C-Sed: sedentary control group; C-Ex: exercised control group; AS-Sed: sedentary aortic stenosis group; AS-Ex: exercised aortic stenosis group; LVDD and LVSD: left ventricular (LV) diastolic and systolic diameter, respectively; BW: body weight; DPWT and SPWT: LV diastolic and systolic posterior wall thickness, respectively; DSWT and SSWT: LV diastolic and systolic septal wall thickness, respectively; RWT: relative wall thickness; AO: aorta diameter; LA: left atrial diameter; LVM: LV mass; LVMI: LVM index. Data are mean ± SD or median and percentiles; ANOVA and Tukey or Mann-Whitney; p < 0.05 versus C-Sed; † p < 0.05 versus C-Ex.
Echocardiographic evaluation of left ventricle systolic function.
| C-Sed ( | C-Ex ( | AS-Sed ( | AS-Ex ( | |
|---|---|---|---|---|
| HR (bpm) | 282 (262–318) | 312 (255–341) | 294 (280–325) | 312 (290–318) |
| EFS % | 51.6 (46.6–55.8) | 50.0 (46.2–51.5) | 46.6 (38.9–54.8) | 43.6 (38.3–47.4)† |
| MFS % | 29.5 (27.6–32.4) | 29.7 (28.4–31.7) | 28.6 (21.1–32.7) | 24.5 (21.6–26.6)† |
| EF | 0.89 (0.85–0.91) | 0.87 (0.84–0.89) | 0.85 (0.77–0.91) | 0.82 (0.76–0.85)† |
| PWSV (mm/s) | 41.1 ± 5.27 | 41.4 ± 7.10 | 31.0 ± 7.14 | 29.1 ± 6.66† |
| Tei index | 0.44 ± 0.08 | 0.43 ± 0.07 | 0.41 ± 0.08 | 0.42 ± 0.11 |
| TDI S′ (average, mm/s) | 3.76 ± 0.72 | 3.58 ± 0.35 | 2.96 ± 0.69 | 2.94 ± 0.49† |
C-Sed: sedentary control group; C-Ex: exercised control group; AS-Sed: sedentary aortic stenosis group; AS-Ex: exercised aortic stenosis group; HR: heart rate; EFS: endocardial fractional shortening; MFS: midwall fractional shortening; EF: ejection fraction; PWSV: posterior wall shortening velocity; Tei index: myocardial performance index; TDI S′: tissue Doppler imaging of systolic velocity of the mitral annulus. ANOVA and Tukey or Mann-Whitney; p < 0.05 versus C-Sed; † p < 0.05 versus C-Ex.
Echocardiographic evaluation of left ventricle diastolic function.
| C-Sed ( | C-Ex ( | AS-Sed ( | AS-Ex ( | |
|---|---|---|---|---|
| Mitral E (cm/s) | 79.5 (73.0–84.0) | 81.5 (76.0–89.0) | 142 (89.0–165) | 145 (85.0–159)† |
| Mitral A (cm/s) | 59.5 (51.0–67.0) | 60.0 (51.0–76.0) | 24.0 (22.0–47.5) | 22.5 (16.0–59.0)† |
| E/A | 1.40 (1.22–1.53) | 1.34 (1.17–1.60) | 5.85 (1.73–7.15) | 7.50 (1.47–9.16)† |
| IVRT (ms) | 24.0 (22.0–26.0) | 22.0 (21.2–26.0) | 18.0 (15.0–22.0) | 16.0 (15.0–22.0)† |
| IVRTn | 53.0 ± 7.25 | 51.2 ± 8.37 | 42.6 ± 11.4 | 39.0 ± 10.2† |
| EDT (ms) | 45.0 (41.0–52.0) | 47.0 (41.0–53.0) | 28.0 (23.0–35.0) | 29.0 (24.5–33.0)† |
| TDI E′ (average mm/s) | 4.37 (3.95–4.95) | 4.50 (4.35–4.92) | 4.25 (3.04–4.90) | 4.17 (3.50–5.25) |
| TDI A′ (average mm/s) | 4.50 ± 1.37 | 4.37 ± 1.21 | 3.79 ± 1.47 | 4.12 ± 1.07 |
| E/TDI E′ (average) | 17.9 (15.8–20.0) | 18.4 (15.7–20.2) | 33.0 (25.7–41.3) | 32.1 (24.8–40.6)† |
C-Sed: sedentary control group; C-Ex: exercised control group; AS-Sed: sedentary aortic stenosis group; AS-Ex: exercised aortic stenosis group. E/A: ratio between early- (E-) to-late (A) diastolic mitral inflow; IVRT: isovolumetric relaxation time; IVRTn: IVRT normalized to heart rate; EDT: E wave deceleration time; TDI E′ and A′: tissue Doppler imaging (TDI) of early (E′) and late (A′) diastolic velocity of mitral annulus. ANOVA and Tukey or Mann-Whitney; p < 0.05 versus C-Sed; † p < 0.05 versus C-Ex.
Figure 1Lipid hydroperoxide concentration (a) and antioxidant enzymes activity in soleus muscle ((b) to (d)). C-Sed: sedentary control group; C-Ex: exercised control group; AS-Sed: sedentary aortic stenosis group; AS-Ex: exercised aortic stenosis group; n: number of animals. Data are mean ± SD (n = 8); ANOVA and Tukey; p < 0.05 versus C-Sed; ‡ p < 0.05 versus AS-Sed.
Gene expression of NADPH oxidase subunits.
| C-Sed ( | C-Ex ( | AS-Sed ( | AS-Ex ( | |
|---|---|---|---|---|
| p22phox | 1.00 ± 0.40 | 0.44 ± 0.15 | 1.10 ± 0.66 | 1.17 ± 0.70† |
| p47phox | 1.00 ± 0.53 | 1.52 ± 0.49 | 0.84 ± 0.48 | 1.21 ± 0.65 |
| NOX2 | 1.00 (0.37–1.39) | 0.33 (0.26–0.75) | 0.82 (0.53–2.16) | 0.63 (0.42–1.07) |
| NOX4 | 1.00 ± 0.52 | 0.70 ± 0.46 | 0.79 ± 0.22 | 0.98 ± 0.32 |
C-Sed: sedentary control group; C-Ex: exercised control group; AS-Sed: sedentary aortic stenosis group; AS-Ex: exercised aortic stenosis group. ANOVA and Tukey or Mann-Whitney; † p < 0.05 versus C-Ex.
Figure 2Soleus muscle NADPH oxidase activity analyzed by reduction of lucigenin (a), total reactive species generation by quantifying two dihydroethidium (DHE) oxidation-derived fluorescent compounds, 2-hydroxyethidium and ethidium, using HPLC ((b) and (c)). C-Sed: sedentary control group; C-Ex: exercised control group; AS-Sed: sedentary aortic stenosis group; AS-Ex: exercised aortic stenosis group; n: number of animals. Data are mean ± SD (n = 8); ANOVA and Tukey; † p < 0.05 versus C-Ex.
Figure 3Protein levels of mitogen-activated protein kinases analyzed by Western blotting. Protein levels were normalized to GAPDH levels. C-Sed: sedentary control group; C-Ex: exercised control group; AS-Sed: sedentary aortic stenosis group; AS-Ex: exercised aortic stenosis group; n: number of animals. Data are mean ± SD (n = 7); ANOVA and Tukey; † p < 0.05 versus C-Ex; ‡ p < 0.05 versus AS-Sed.